Effect of Saccharomyces cerevisiae var. Boulardii and β-galactomannan oligosaccharide on porcine intestinal epithelial and dendritic cells challenged in vitro with Escherichia coli F4 (K88)
© Badia et al; licensee BioMed Central Ltd. 2012
Received: 21 June 2011
Accepted: 25 January 2012
Published: 25 January 2012
Probiotic and prebiotics, often called "immune-enhancing" feed additives, are believed to deal with pathogens, preventing the need of an immune response and reducing tissue damage. In this study, we investigated if a recently developed β-galactomannan (βGM) had a similar protective role compared to Saccharomyces cerevisiae var. Boulardii (Scb), a proven probiotic, in the context of enterotoxigenic Escherichia coli (ETEC) infection. ETEC causes inflammation, diarrhea and intestinal damage in piglets, resulting in large economic loses worldwide. We observed that Scb and βGM products inhibited in vitro adhesion of ETEC on cell surface of porcine intestinal IPI-2I cells. Our data showed that Scb and βGM decreased the mRNA ETEC-induced gene expression of pro-inflammatory cytokines TNF-α, IL-6, GM-CSF and chemokines CCL2, CCL20 and CXCL8 on intestinal IPI-2I. Furthermore, we investigated the putative immunomodulatory role of Scb and βGM on porcine monocyte-derived dendritic cells (DCs) per se and under infection conditions. We observed a slight up-regulation of mRNA for TNF-α and CCR7 receptor after co-incubation of DC with Scb and βGM. However, no differences were found in DC activation upon ETEC infection and Scb or βGM co-culture. Therefore, our results indicate that, similar to probiotic Scb, prebiotic βGM may protect intestinal epithelial cells against intestinal pathogens. Finally, although these products may modulate DC activation, their effect under ETEC challenge conditions remains to be elucidated.
The infection by enterotoxigenic Escherichia coli (ETEC) is one on the most important causes of neonatal and post-weaning diarrhea (PWD) in piglets. ETEC causes significant morbidity and mortality, resulting in a large economic loses in the porcine industry. One of the most common ETEC in swine is serotype 0149 which carries the K88 (F4) adhesin that enables the attachment of the bacteria to the intestinal epithelium. ETEC colonizes ileum [1, 2], penetrate the epithelium and its pathogenesis is ascribed to the production of different combination of heat-labile (LT) and heat-stable (ST) enterotoxins [3, 4].
Antibiotic growth promoters (AGPs) have been long used in animal feeding to prevent neonatal and PWD in piglets. The use of AGPs increases the prevalence of bacteria resistant to antibiotics in farm animals and constitutes a potential risk of antibiotic resistance transference to human pathogenic bacteria, following to consumption of animal derived products . The European ban of AGPs in animal production (EC 1831/2003) increased the need to develop new alternatives  to control and prevent animal colonization by pathogenic bacteria and somehow guarantee animal welfare and food safety.
Probiotics and prebiotics are interesting alternatives to AGP for animal feeding. They are believed to control pathogenic bacteria colonization and to enhance the mucosal immune system, resulting in a decreased pathogenic load and improving animal welfare . The yeast Saccharomyces cerevisiae var. Boulardii (Scb) is a well-known probiotic with proven effects for the treatment and prevention of gastrointestinal diseases (see  for review). Typically, between 30-60% of Saccharomyces yeast wall is composed by polysaccharides  and specifically mannose and galactose mannans represent respectively more than 50 μg/mg of yeast dry mass . Our center (Institut de Recerca i Tecnologia Agroalimentàries, IRTA) developed a highly rich β-galactomannan prebiotic (βGM) from the carob bean of the Ceratonia silliqua tree that as non-digestible food prebiotic ingredient may beneficially affect the host.
Intestinal epithelial cells (IECs) and dendritic cells (DC) of the gut are crucial for maintaining immunological tolerance to environmental, food antigens and commensal bacteria, but also to develop strong responses to invading pathogens when required [11, 12]. Recent studies have demonstrated that IECs are far from being a simple physical barrier to the external environment. Pathogen associated molecular patterns (PAMPS) are recognized by Pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs), expressed on IECs membranes , leading to the activation of proinflammatory pathways, as nuclear factor-κB (NF-κ-B) and activator protein 1 (AP1), related to cytokines and chemokines that coordinate the innate immune response .
Our work intended to establish an in vitro screening of an already known probiotic (Scb) and new developed prebiotic (βGM) to promote their use in animal feeding. First, we focused on antimicrobial activity and bacterial adhesion studies of these products on the IECs and how they may enhance an effective maintenance of the intestinal barrier. Furthermore, we studied their ability to modulate DCs which are pivotal for linking innate and adaptive immune response against pathogens. We were especially interested in the role of both cells types in cytokine and chemokine networks that regulate the homeostasis in the gastrointestinal tract .
Materials and methods
Intestinal epithelial cell culture
The porcine small intestine epithelial cell line IPI-2I (ECACC 93100622) was established from the ileum of an adult boar (SLAd/d haplotype) . IPI-2I cells were maintained in DMEM (Invitrogen, Cergy Pontoise, France) supplemented with 10% FCS (Sigma-Aldrich, Saint-Quentin, France), 4 mM L-glutamine (Invitrogen), insulin 10 μg/mL (Sigma-Aldrich), 100 U/mL penicillin and 100 μg/mL streptomycin (Invitrogen). In all experiments, cells were cultured in 6-well plates (Falcon) to confluence. Before the addition of pre/probiotics and/or infection, cells were washed three times to remove antibiotics and culture media was replaced by DMEM media (Invitrogen) containing 4 mM L-glutamine (Invitrogen) and insulin 10 μg/mL (Sigma-Aldrich). Cells were used between passages 30-50 and periodically tested to avoid Mycoplasma contamination (MycoAlert® Mycoplasma Detection Kit, Lonza).
Probiotic and prebiotic preparation
Lyophilized Saccharomyces cerevisiae var. Boulardii (Scb, Biocodex, Laboratoires Montrouge, France) was rehydrated with 10 mL of DMEM and incubated for 30 min at 30°C. Then, yeast was counted with a Neubauer cell counter and methyl blue to exclude non-viable yeast. The yeast was added to the selected wells (multiplicity of infection, MOI = 3) and incubated overnight at 37°C and 10% CO2.
Commercially prebiotic Salmosan® (patent WO2009/144070 A2, licensed by Industrial Técnica Pecuaria, ITPSA, Barcelona, Spain) contains more than 98% of β-galactomannan (βGM) which is a β-(1-4)-mannose backbone with branched galactose molecules (ratio galactose:mannose 1:4) . Commercially prebiotic Salmosan® also contain less than 1% of other polysaccharides such as xylose, fructose, arabinose, glucose, galactosamine and fucose derived from the carob bean gum and the seed of the Ceratonia silliqua tree. This is product is industrially treated to become soluble in gut. βGM is was diluted in DMEM (1 mg/mL), homogenized and incubated 30 min at 37°C. Immediately before the infection, βGM was added to each well at 10 μg/mL.
Host cell-pathogen assay
Two pathogenic E.coli K88 (ETEC) strains were used in the host-pathogen assays. Initially, ETEC 56190 F4+ (K88ad, O8:K87:H19, LT+ and STb+) from INRA collection was used for cytokine and chemokine mRNA assays. For adhesion assays and cytokine protein secretion we used strain ETEC GN1034 F4+ (K88+, LT+, STa+ and STb+) provided by Dr Ignacio Badiola (Centre de Recerca en Sanitat Animal,CReSA, IRTA-UAB, Spain) which was more adherent to IPI-2I cells . Both ETEC strains were preserved frozen in glycerol 15% at -80°C until their use. Before infection, 50 μL of ETEC were added to 20 mL of Luria-Bertrani media (LB) and cultured for 3-4 h at 37°C with 180 rpm rotational agitation (Multitron HT, Infors). For the infection, ETEC was used at exponential growth phase by determination of absorbance at 600 nm. ETEC was used at MOI = 10, previously determined by cytotoxic lactate dehydrogenase activity assay (Cytotoxicity Detection Kit Plus LDH, Roche). In vitro challenge lasted 3 h for gene expression and bacterial adherence studies or 24 h for supernatant cytokine determination. After host cell-pathogen co-culture, cells or supernatants were respectively sampled and stored until their analysis.
Bacterial adherence assay
Isolation of mRNA and cDNA synthesis
Total RNA was isolated from homogenized cells using Trizol reagent (Invitrogen) and RNeasy MiniKit (Qiagen, Courtaboeuf, France). Then, RNA samples were treated with DNase I Amp Grade (Invitrogen) (1 U/μg of RNA). RNA concentration was determined by measuring optical density at 260 nm (OD260) and the RNA quality was assessed by calculating OD260/OD280 ratio and by capillary electrophoresis (Agilent 2100 Bioanalyzer, Agilent Technologies Inc., Santa-Clara, USA). A total of 1 μg of RNA was incubated in a final volume of 20 μL containing 2 μL dNTP (0.25 mM final each), 1.3 μL oligodT (133 pmoles/μL), 0.8 μL MuMLV reverse transcriptase (25 U/μL), 4 μL 5 × MuMLV buffer (Eurogentec, Liège, Belgium) and 1.9 μL of ultra-pure water (Gibco, Paisley, Scotland). The reaction was maintained for 90 min at 37°C and then heat-inactivated at 93°C for 5 min. The generated cDNA was stored at -80°C.
Messenger RNA expression analysis using quantitative real-time PCR
Primer sequences and annealing temperatures of primer sets (°C), expected PCR fragment sizes (bp) and associated references.
Determination of cytokine production
Cytokine protein determination in the culture supernatant was performed by enzyme-linked immunosorbent assays (ELISAs). Host cell-pathogen assay was performed as described above but to avoid bacterial overgrowth Gentamycin 100 μg/mL (Sigma-Aldrich) was added to each well. Cell culture supernatant was collected after 24 h and stored at -80°C until analysis. Swine IL-6 and CXCL8 DuoSet ELISA from R&D Systems (Vitro SP, Spain) were used according to manufacturer's recommendations.
Isolation of peripheral blood monocytes and differentiation of monocyte derived dendritic cells
Blood samples were obtained from 6 to 12-month old large white pigs at the slaughter house. Blood was collected into heparinised tubes and followed the protocol described by Pilon et al.,  with few modifications. Briefly, peripheral blood monocytes (PBMC) were isolated by centrifugation (1000 g × 30 min) over Ficoll (d = 1.077, Histopaque, Sigma-Aldrich). Red blood lysing solution (Sigma-Aldrich) was used to remove remaining erythrocytes. Then, cells were resuspended in RPMI glutamax (Gibco, Invitrogen) containing 2.5% FBS, 1% Pen/strep and 50 μM of 2-β-mercaptoethanol (Sigma-Aldrich). Next, 150 × 106 cells/20 mL were plated in 150 cm2 cellBind flasks (Corning, Afora, Spain) and incubated for 30 min at 37°C and 5% CO2. Then, flasks were washed with RPMI to remove all non-adherent cells (lymphocytes). To induce differentiation, monocytes were cultured with RPMI glutamax media containing 1% Pen/Strep antibiotic, 10% FBS, 50 μM β-mercaptoethanol and swine recombinant cytokines IL4 (100 ng/mL) and GM-CSF (20 ng/mL) (Biosource, Invitrogen) for 6 days at 37°C and 5% CO2. On day 3, fresh medium and cytokines were added at the same concentrations as previously.
Dendritic cell phenotyping
After 6 days of culture, cells showed typical DC cell morphology, defined by large cytoplasmic cell mass and long dendrites. In addition, DCs were characterised as CD172a+ (SWC3), SLA class II-DQ+, SLA class II-DR+, CD80/86+, CD14mod and CD11R1-. Antibodies for cell surface markers CD172a/SWC3, SLA class II -DQ, SLA class II-DR and CD11R1 were provided by Dr J. Domínguez (INIA, Madrid, Spain). Antibody for CD14 determination was purchased from Acris Antibodies (AntibodyBCN, Barcelona, Spain) and for CD80/CD86 we used recombinant human Cytotoxic T-lymphocyte associated molecule-4/Fc fusion protein (CTLA4-Fc IgG1, Invitrogen). The FITC-conjugated anti-human immunoglobulin IgG1 or Zenon tricolor mouse IgG1 and IgG2a labelling kits (Invitrogen) were used for detection by flow cytometry (FACSCanto™ using FACSDiva™ software; BD Biosciences, San José, California, USA).
Pathogen induced dendritic cell activation
After 6 days of culture, DCs were recovered and adjusted to 5 × 105- 1 × 106 DC/well into 24-well plates. Then, DCs were incubated with Scb (MOI = 3) or βGM (10 μg/mL) and challenged with ETEC (MOI = 5). After 3 h of exposure, supernatants were discarded and cells were collected in Trizol reagent. Isolation of DCs mRNA and gene expression studies was performed as described above.
All statistical analyses were performed using PROC GLM by SAS Software version 9.1.3 (SAS institute, Carey, NC, USA). Means for adhesion percentages, mRNA and protein secretion were considered in a factorial design 2 × 3 (2 infection level * 3 experimental treatments) with Duncann post-test grouping for analysis. The P value ≤ 0.05 was considered to be significant.
Cytokine and chemokine mRNA expression of IPI-2I cells
The addition of Scb on IPI-2I cells induced a 50% inhibition of the ETEC-induced mRNA expression of TNFα, GM-CSF and CCL20 (p < 0.01) (Figure 2). Furthermore, Scb reduced the ETEC-induced mRNA expression for IL1α, IL6, CCL2 and CXCL8 genes to unchallenged control level (Figure 2). Similar to Scb, addition of βGM (10 μg/mL) down-regulated the ETEC-induced mRNA expression of TNFα, GM-CSF, CCL2, IL6 and CCL20 in infected cells (p < 0.01). Inhibition of CXCL8 was smaller in βGM treated cells (×1.5, p < 0.05, Figure 2) compared to Scb (×4). Finally, βGM did not inhibit IL1α ETEC-induced mRNA.
Cytokine and chemokine secretion
Modulation of mRNA expression of monocyte derived dendritic cells
The mere addition of Scb (MOI = 3) or βGM (10 μg/mL) triggered a slight but statistically significant up-regulation of TNFα (×2.7 and ×2 respectively) and CCR7 mRNA (×1.6) compared to the control with medium (Figure 4, p < 0.05). Both products also enhanced gene expression for GM-CSF (×5 and ×1.6). However, only Scb induced gene expression of IL6 (×3.3) and IL10 (×2.3) (Figure 4, p < 0.05).
The ETEC-induced mRNA expression of DCs co-cultured with Scb (MOI = 3) or βGM (10 μg/mL) was similar to infected control (Figure 4) for TNFα, CCR7, TLR4, TLR2, BAFF, APRIL and TGFβ genes. Therefore no synergistic or antagonistic effect was observed for these genes related to DCs activation. However, ETEC-induced mRNA expression of IL10 and CCL17 was 2.3-fold inhibited in βGM treated DCs (p < 0.05, Figure 4).
After European ban of antibiotic growth promoters for animal feeding (EC 1831/2003), probiotics and prebiotics have been postulated as promising alternatives to AGPs in animal feeding . This work studied the effect of a new commercial prebiotic compared to an already proven probiotic on porcine IECs and DCs in the context of an ETEC in vitro infection. Besides to provide selective advantages to microbiota and to exclude pathogens, prebiotics are believed to mimic the host cell receptor which the pathogen adheres. Mannose derivates are described to bind to Type I fimbriae or pili which contains multiple-subunits of lectins that bind to mannan units of the glycoproteins on the surface of host cells [27, 28]. In that sense, Shoaf et al. , tested several commercially available non-digestible oligosaccharides (NDOs) with different molecular structures. The latter highlighted that galactoligosaccharides had higher inhibition of E.coli adherence on Caco-2 and Hep-2 cells in a dose dependent manner. Similar to NDOs, yeast probiotic properties, such as Saccharomyces cerevisiae, are specie- or strain- specific . The ability of Scb to aggregate enterohaemorrhagic E.coli (EHEC) on their cell wall though type I fimbriae recognition was described by Gedek B. R . However, ETEC K88 bears F4 fimbriae , which is described as mannose-resistant in the agglutination test with 0.5% D-mannose . Nevertheless, all three variants of K88 adhesin expressed on the tip of the F4 fimbriae recognize carbohydrate structures expressed on host cell glycoconjugates  such as sialoglycoproteins, intestinal mucin-type glycoproteins and neutral glycosphingolipids . Indeed, β-linked galactose residues have been found to be essential component in the attachment of K88 fimbriae to mucus K88 receptors [35, 36]. Our results show that addition of Scb or βGM, reduces the adhesion of ETEC on the surface of porcine intestinal epithelial IPI-2I cell approximately to 80%. Together, these data confirm that products highly rich in galactose residues, like our βGM and Scb, may bind to K88 adhesin , suggesting their role as a prophylactic agent to gastrointestinal infections in pigs [37, 38].
The enterotoxigenic E.coli K88 (ETEC) in vitro infection causes a proinflammatory transcriptional profile on porcine intestinal cells IPI-2I, upregulating gene expression cytokines TNFα, GM-CSF involved in proliferation and activation of neutrophils, IL1α, IL6 (acute phase reactions, proliferation and differentiation of macrophages and B-cells) as well as proinflammatory chemokines CXCL8 (neutrophil recruitment), CCL2 (MCP-1, Monocyte chemotactic protein-1), CXCL2 and CCL20 chemotactic for immature DCs involved in the bacterial uptake across the epithelial barrier. These results are in accordance to results of Eckmann et al., , but contrary to data published by Pavlova et al.,  who found no differences in mRNA expression of cytokine TNFα and chemokine CXCL8 after in vitro attachment of different serotypes of ETEC on IPI-2I cells. However, response of IPI-2I cells under challenge conditions and mRNA expression of genes TNFα and CXCL8 has been already demonstrated in the gene expression study performed by Mariani et al., , as well as in different host-pathogen interaction studies where IPI-2I were infected by another Gram negative pathogen as Salmonella; Salmonella lipopolysaccharide (LPS)  or even Enteamoeba hystolytica parasite . The explanation for these contradictory results may be due the difference in cell culture conditions (see Mariani et al., ) or to the specificity of the ETEC serotype used in each study. In our model, presence of ETEC or their bacterial constituents such as LPS or flagellin induces a two to tenfold increase in mRNA expression of proinflammatory genes in IPI-2I cells compared to the non-infected cells. At the protein level, data for IL6 and CXCL8 in infected IPI-2I cells (Figure 3) are comparable to protein secretion of pig intestinal IPEC-J2 cells shown by Devriendt et al. , as a response of TLR5 signalling cascade upon recognition of ETEC F4 flagellin. Addition of Scb or βGM down-regulate ETEC-induced gene expression of TNFα, GM-CSF, IL6, CCL2, CXCL2 and CCL20, reducing the overall proinflammatory state caused by ETEC. This effect is not induced for mRNA of IL1α nor CXCL8 in βGM treated cells compared to the Scb treatment, but no difference was shown between IL6 and CXCL8 in the reduction of mRNA or protein expression.
In accordance to current data, probiotic Scb has been shown to secrete anti-inflammatory factors smaller than 10 kDa  that have inhibitory effects on mRNA expression of cytokine IL1-α, IL6 as well as chemokines CXCL2 and CXCL8 on IPI-2I cells co-cultured with ETEC . These anti-inflammatory properties have been related to direct blocking of nuclear factor-kappa B (NFkB) and mitogen associated protein kinase (MAPK) activation  or by indirect neutralization of ETEC toxins . Recently, Zanello et al.  demonstrated that Saccharomyces cerevisiae inhibition on proinflammatory transcripts in porcine intestinal cells IPEC-1 co-cultured with ETEC was associated to the decrease of ERK1/2 and p38 MAPK phosphorylation. Related to NDOs, beneficial role of βGM from partially hydrolyzed guar gum was described to prevent mucosal damage in dextran sulphate sodium (DSS) induced colitis in mice  by a decrease of TNFα mRNA/protein and neutrophil infiltration. Future studies should determine the role of NDOs and especially βGM on the molecular signaling pathways involved in regulation of IECs upon ETEC infection.
Probiotics and prebiotics are believed to be recognized by PRRs expressed on dendritic cells (DCs) located in the subepithelial dome (SED) and/or to extend their dendrites between epithelial cells to the lumen. We aimed to establish if optimal concentrations of Scb or βGM for IECs also modulate DC activation or maturation per se and/or under ETEC infection. In our work, brief incubation (3 h) with Scb or βGM induced a slightly activation of DC observed by an up-regulation of mRNA for TNFα and CCR7 coreceptor (Figure 4). Recently, Santander et al.  described that long exposure (~48 h) to βGM from Caesalpinia spinosa plant extracts induce phenotypic maturation of human DC characterized by CD83, CD86, CD206 and HLA-DR and increase mRNA for IL1β, IL6, CXCL8 and IL12p70 cytokines.
The ETEC-induced maturation of porcine DCs is mainly induced by flagellin, through Fcγ receptor ligation , among other bacterial constituents such as F4 and LPS [49, 50]. We observed that ETEC up-regulated mRNA level of CCR7, receptor for CCL19 and CCL21, which provides DC signal for entry into the inductive sites of the adaptive immune system such as the lymph node. Furthermore, there was an increase in BAFF and APRIL, members of the tumor necrosis factor superfamily involved in T-cell-independent IgA class-switch recombination (CSR). Additionally, ETEC recognition by TLR4 induced up-regulation of this receptor and activated the gene expression of cytokines TNFα, GM-CSF, CCL17 and IL6. Finally, IL10 mRNA was increased in challenged DCs, probably to limit over-whelming specific and unspecific immune response and to avoid tissue damage . Although no phenotypic study was performed in this work, published data  indicate that porcine monocyte-derived DC are expected to increase cell surface co-stimulatory molecules CD80/C86 and protein TNFα, IL6 and CXCL8 secretion after TLR ligand recognition.
In our study, co-incubation of porcine DCs with Scb or βGM and ETEC did not trigger significant differences on DCs maturation compared to infected control for the most of the genes studied. In contrast, Sonck et al.  found that effects of β-glucans on DC maturation differ according to their origin, while Saccharomyces cerevisiae derived β-glucan Macrogard induced mature phenotype determined by upregulation of DC activation markers (CD80/86, CD40 and MHC class II), curdlan enhanced expression of cytokines IL-1β, IL-6, IL-10 and IL-12/IL-23p40. Related to prebiotics, Wismar et al.  found that galactomannans from guar gum at high concentrations (~200 μg/mL) directly stimulate mice DCs and modulate DC maturation induced by microbial signals, such as LPS, leading to a synergistically increased TNFα and IL10 proteins and suppression of IL-12p70. Indeed, Sheng et al.  showed that mannan and mannan associated structures activate TLR4 signalling pathways in a dose dependent manner, induce DCs mature phenotype (CD40, CD80 and CD86) and up-regulate proinflammatory mRNA for IL1-β and TNFα cytokines as well as other Th1/Th2 cytokines. Considering that origin, structure and size of mannans or β-glucans is crucial to determine their immune regulatory role , differences in product concentration and time exposure may explain our contrary results.
The beneficial role of these products remains to be elucidated on DCs activation under ETEC infection, as well as for other cell types involved in the mucosal immune response, such as monocytes/macrophages or neutrophils. In addition to evaluate Scb and βGM in in vivo trials, research approaches as three-dimensional co-culture  or gut-loop intestinal models  may determine effect of Scb and βGM on the cross-talk of IECs, DCs and other cell types under ETEC infection.
To summarize, present findings describe the protective role of probiotic Saccharomyces cerevisiae var. Boulardii and a recently developed prebiotic β-galactomannan, to prevent E.coli K88 infection using an in vitro model for pig intestinal cells, and consequently their ability to reduce pathogenic inflammation. These results may lead to in vivo trials to assess the suitability of probiotic Scb and prebiotic βGM as alternative to antibiotics growth promoters in animal production.
List of abbreviations
A proliferation-inducing ligand
B-cell activating factor
chemokine: C-C motif) ligand
chemokine: C-X-C motif) ligand
Enterotoxigenic Escherichia coli K88
Granulocyte/Macrophage Colony-Stimulating Factor
Intestinal epithelial cells
Pathogen associated molecular patterns
Pattern recognition receptors
- Scb :
(Saccharomyces cerevisiae var. Boulardii
Toll like receptor
Tumor necrosis factor-α).
This work was supported by grants from the French National Institute for Agricultural Research (INRA, France) and grant AGL 2009-11936 of the Ministerio de Ciencia e Innovación (MICIIN, Spain). We gratefully acknowledge Dr I. Badiola (CReSA) for providing ETEC GN1034 strain and Dr J. Domínguez-Juncal (Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, INIA, Madrid, Spain) for kindly providing antibodies for pig cell surface markers.
- Nagy B, Arp LH, Moon HW, Casey TA: Colonization of the small intestine of weaned pigs by enterotoxigenic Escherichia coli that lack known colonization factors. Vet Pathol. 1992, 29: 239-246. 10.1177/030098589202900308.View ArticlePubMedGoogle Scholar
- Girard MP, Steele D, Chaignat CL, Kieny MP: A review of vaccine research and development: human enteric infections. Vaccine. 2006, 24: 2732-2750. 10.1016/j.vaccine.2005.10.014.View ArticlePubMedGoogle Scholar
- Shoaf K, Mulvey GL, Armstrong GD, Hutkins RW: Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Infect Immun. 2006, 74: 6920-6928. 10.1128/IAI.01030-06.PubMed CentralView ArticlePubMedGoogle Scholar
- Pavlova B, Volf J, Alexa P, Rychlik I, Matiasovic J, Faldyna M: Cytokine mRNA expression in porcine cell lines stimulated by enterotoxigenic Escherichia coli. Vet Microbiol. 2008, 132: 105-110. 10.1016/j.vetmic.2008.04.024.View ArticlePubMedGoogle Scholar
- World Health Organisation: The Medical Impact of the use of antimicrobials in food animals. 13-17 October; Berlin, Germany. 1997Google Scholar
- Brufau J: Animal feeding in Europe: challenges and opportunities. Nutritional biotechnology in the feed and food industries. Edited by: Lyons TP, Jacques KA. 2003, Notthingham University PressGoogle Scholar
- Gaggìa F, Mattarelli P, Biavati B: Probiotics and prebiotics in animal feeding for safe food production. Int J Food Microbiol. 2010, 141 (Suppl 1): S15-28.View ArticlePubMedGoogle Scholar
- Zanello G, Meurens F, Berri M, Salmon H: Saccharomyces boulardii effects on gastrointestinal diseases. Curr Issues Mol Biol. 2009, 11: 47-58.PubMedGoogle Scholar
- Morales-López R, Auclair E, García F, Esteve-Garcia E, Brufau J: Use of yeast cell walls; beta-1, 3/1, 6-glucans; and mannoproteins in broiler chicken diets. Poult Sci. 2009, 88: 601-607. 10.3382/ps.2008-00298.View ArticlePubMedGoogle Scholar
- Czerucka D, Piche T, Rampal P: Review article: yeast as probiotics -- Saccharomyces boulardii. Aliment Pharmacol Ther. 2007, 26: 767-778. 10.1111/j.1365-2036.2007.03442.x.View ArticlePubMedGoogle Scholar
- Oswald IP: Role of intestinal epithelial cells in the innate immune defence of the pig intestine. Vet Res. 2006, 37: 359-368. 10.1051/vetres:2006006.View ArticlePubMedGoogle Scholar
- Summerfield A, McCullough KC: The porcine dendritic cell family. Dev Comp Immunol. 2009, 33: 299-309. 10.1016/j.dci.2008.05.005.View ArticlePubMedGoogle Scholar
- Artis D: Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol. 2008, 8: 411-420. 10.1038/nri2316.View ArticlePubMedGoogle Scholar
- Sansonetti PJ: War and peace at mucosal surfaces. Nat Rev Immunol. 2004, 4: 953-964. 10.1038/nri1499.View ArticlePubMedGoogle Scholar
- Cloeckaert A, Schwarz S: Molecular characterization, spread and evolution of multidrug resistance in Salmonella enterica typhimurium DT104. Vet Res. 2001, 32: 301-310. 10.1051/vetres:2001126.View ArticlePubMedGoogle Scholar
- Kaeffer B, Bottreau E, Velge P, Pardon P: Epithelioid and fibroblastic cell lines derived from the ileum of an adult histocompatible miniature boar (d/d haplotype) and immortalized by SV40 plasmid. Eur J Cell Biol. 1993, 62: 152-162.PubMedGoogle Scholar
- Warrand J: Healthy polysaccharides. Food Technol Biotech. 2006, 44: 355-370.Google Scholar
- Zanello G, Meurens F, Berri M, Chevaleyre C, Melo S, Auclair E, Salmon H: Saccharomyces cerevisiae decreases inflammatory responses induced by F4+ enterotoxigenic Escherichia coli in porcine intestinal epithelial cells. Vet Immunol Immunopathol. 2011, 141: 133-138. 10.1016/j.vetimm.2011.01.018.View ArticlePubMedGoogle Scholar
- Elsinghorst EA: Measurement of invasion by gentamicin resistance. Methods Enzymol. 1994, 236: 405-420.View ArticlePubMedGoogle Scholar
- Bruel T, Guibon R, Melo S, Guillén N, Salmon H, Girard-Misguich F, Meurens F: Epithelial induction of porcine suppressor of cytokine signaling 2 (SOCS2) gene expression in response to Entamoeba histolytica. Dev Comp Immunol. 2010, 34: 562-571. 10.1016/j.dci.2009.12.017.View ArticlePubMedGoogle Scholar
- Meurens F, Berri M, Auray G, Melo S, Levast B, Virlogeux-Payant I, Chevaleyre C, Gerdts V, Salmon H: Early immune response following Salmonella enterica subspecies enterica serovar Typhimurium infection in porcine jejunal gut loops. Vet Res. 2009, 40: 5-10.1051/vetres:2008043.View ArticlePubMedGoogle Scholar
- Levast B, de Monte M, Chevaleyre C, Melo S, Berri M, Mangin F, Zanello G, Lantier I, Salmon H, Meurens F: Ultra-early weaning in piglets results in low serum IgA concentration and IL17 mRNA expression. Vet Immunol Immunopathol. 2010, 137: 261-268. 10.1016/j.vetimm.2010.06.004.View ArticlePubMedGoogle Scholar
- Meurens F, Berri M, Siggers RH, Willing BP, Salmon H, Van Kessel AG, Gerdts V: Commensal bacteria and expression of two major intestinal chemokines, TECK/CCL25 and MEC/CCL28, and their receptors. PLoS One. 2007, 2: e677-10.1371/journal.pone.0000677.PubMed CentralView ArticlePubMedGoogle Scholar
- Nygard AB, Jørgensen CB, Cirera S, Fredholm M: Selection of reference genes for gene expression studies in pig tissues using SYBR green qPCR. BMC Mol Biol. 2007, 8: 67-10.1186/1471-2199-8-67.PubMed CentralView ArticlePubMedGoogle Scholar
- Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3: RESEARCH0034Google Scholar
- Pilon C, Meurens F, Dauba A, Salmon H, Velge-Roussel F, Lebranchu Y, Baron C: Induction of porcine regulatory cells by mycophenolic Acid-treated dendritic cells. Transplant Proc. 2009, 41: 700-702. 10.1016/j.transproceed.2008.12.004.View ArticlePubMedGoogle Scholar
- Sharon N: Carbohydrates as future anti-adhesion drugs for infectious diseases. Biochim Biophys Acta. 2006, 1760: 527-537. 10.1016/j.bbagen.2005.12.008.View ArticlePubMedGoogle Scholar
- Althouse C, Patterson S, Fedorka-Cray P, Isaacson RE: Type 1 fimbriae of Salmonella enterica serovar Typhimurium bind to enterocytes and contribute to colonization of swine in vivo. Infect Immun. 2003, 71: 6446-6452. 10.1128/IAI.71.11.6446-6452.2003.PubMed CentralView ArticlePubMedGoogle Scholar
- van der Aa Kühle A, Skovgaard K, Jespersen L: In vitro screening of probiotic properties of Saccharomyces cerevisiae var. boulardii and food-borne Saccharomyces cerevisiae strains. Int J Food Microbiol. 2005, 101: 29-39. 10.1016/j.ijfoodmicro.2004.10.039.View ArticlePubMedGoogle Scholar
- Gedek BR: Adherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses. 1999, 42: 261-264. 10.1046/j.1439-0507.1999.00449.x.View ArticlePubMedGoogle Scholar
- Devriendt B, Stuyven E, Verdonck F, Goddeeris BM, Cox E: Enterotoxigenic Escherichia coli (K88) induce proinflammatory responses in porcine intestinal epithelial cells. Dev Comp Immunol. 2010, 34: 1175-1182. 10.1016/j.dci.2010.06.009.View ArticlePubMedGoogle Scholar
- Nagy B, Fekete PZ: Enterotoxigenic Escherichia coli in veterinary medicine. Int J Med Microbiol. 2005, 295: 443-454. 10.1016/j.ijmm.2005.07.003.View ArticlePubMedGoogle Scholar
- Jin LZ, Zhao X: Intestinal receptors for adhesive fimbriae of enterotoxigenic Escherichia coli (ETEC) K88 in swine--a review. Appl Microbiol Biotechnol. 2000, 54: 311-318. 10.1007/s002530000404.View ArticlePubMedGoogle Scholar
- Sarabia-Sainz AI, Ramos-Clamont G, Candia-Plata MM, Vázquez-Moreno L: Biorecognition of Escherichia coli K88 adhesin for glycated porcine albumin. Int J Biol Macromol. 2009, 44: 175-181. 10.1016/j.ijbiomac.2008.11.009.View ArticlePubMedGoogle Scholar
- Payne D, O'Reilly M, Williamson D: The K88 fimbrial adhesin of enterotoxigenic Escherichia coli binds to beta 1-linked galactosyl residues in glycosphingolipids. Infect Immun. 1993, 61: 3673-3677.PubMed CentralPubMedGoogle Scholar
- Grange PA, Mouricout MA, Levery SB, Francis DH, Erickson AK: Evaluation of receptor binding specificity of Escherichia coli K88 (F4) fimbrial adhesin variants using porcine serum transferrin and glycosphingolipids as model receptors. Infect Immun. 2002, 70: 2336-2343. 10.1128/IAI.70.5.2336-2343.2002.PubMed CentralView ArticlePubMedGoogle Scholar
- Becker PM, Galletti S: Food and feed components for gut health-promoting adhesion of E. coli and Salmonella enterica. J Sci Food Agric. 2008, 88: 2026-2035. 10.1002/jsfa.3324.View ArticleGoogle Scholar
- White LA, Newman MC, Cromwell GL, Lindemann MD: Brewers dried yeast as a source of mannan oligosaccharides for weanling pigs. J Anim Sci. 2002, 80: 2619-2628.PubMedGoogle Scholar
- Eckmann L, Kagnoff MF: Intestinal mucosal responses to microbial infection. Springer Semin Immunopathol. 2005, 27: 181-196. 10.1007/s00281-005-0207-5.View ArticlePubMedGoogle Scholar
- Mariani V, Palermo S, Fiorentini S, Lanubile A, Giuffra E: Gene expression study of two widely used pig intestinal epithelial cell lines: IPEC-J2 and IPI-2I. Vet Immunol Immunopathol. 2009, 131: 278-284. 10.1016/j.vetimm.2009.04.006.View ArticlePubMedGoogle Scholar
- Volf J, Boyen F, Faldyna M, Pavlova B, Navratilova J, Rychlik I: Cytokine response of porcine cell lines to Salmonella enterica serovar typhimurium and its hilA and ssrA mutants. Zoonoses Public Health. 2007, 54: 286-293. 10.1111/j.1863-2378.2007.01064.x.View ArticlePubMedGoogle Scholar
- Arce C, Ramírez-Boo M, Lucena C, Garrido JJ: Innate immune activation of swine intestinal epithelial cell lines (IPEC-J2 and IPI-2I) in response to LPS from Salmonella typhimurium. Comp Immunol Microbiol Infect Dis. 2010, 33: 161-174. 10.1016/j.cimid.2008.08.003.View ArticlePubMedGoogle Scholar
- Meurens F, Girard-Misguich F, Melo S, Grave A, Salmon H, Guillén N: Broad early immune response of porcine epithelial jejunal IPI-2I cells to Entamoeba histolytica. Mol Immunol. 2009, 46: 927-936. 10.1016/j.molimm.2008.09.036.View ArticlePubMedGoogle Scholar
- Sougioultzis S, Simeonidis S, Bhaskar KR, Chen X, Anton PM, Keates S, Pothoulakis C, Kelly CP: Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression. Biochem Biophys Res Commun. 2006, 343: 69-76. 10.1016/j.bbrc.2006.02.080.View ArticlePubMedGoogle Scholar
- Pothoulakis C: Review article: anti-inflammatory mechanisms of action of Saccharomyces boulardii. Aliment Pharmacol Ther. 2009, 30: 826-833. 10.1111/j.1365-2036.2009.04102.x.PubMed CentralView ArticlePubMedGoogle Scholar
- Zanello G, Berri M, Dupont J, Sizaret PY, D'Inca R, Salmon H, Meurens F: Saccharomyces cerevisiae modulates immune gene expressions and inhibits ETEC-mediated ERK1/2 and p38 signaling pathways in intestinal epithelial cells. PLoS One. 2011, 6: e18573-10.1371/journal.pone.0018573.PubMed CentralView ArticlePubMedGoogle Scholar
- Naito Y, Takagi T, Katada K, Uchiyama K, Kuroda M, Kokura S, Ichikawa H, Watabe J, Yoshida N, Okanoue T, Yoshikawa T: Partially hydrolyzed guar gum down-regulates colonic inflammatory response in dextran sulfate sodium-induced colitis in mice. J Nutr Biochem. 2006, 17: 402-409. 10.1016/j.jnutbio.2005.08.010.View ArticlePubMedGoogle Scholar
- Santander SP, Aoki M, Hernandez JF, Pombo M, Moins-Teisserenc H, Mooney N, Fiorentino S: Galactomannan from Caesalpinia spinosa induces phenotypic and functional maturation of human dendritic cells. Int Immunopharmacol. 2011, 11: 652-660. 10.1016/j.intimp.2011.01.006.View ArticlePubMedGoogle Scholar
- Devriendt B, Verdonck F, Summerfield A, Goddeeris BM, Cox E: Targeting of Escherichia coli F4 fimbriae to Fcgamma receptors enhances the maturation of porcine dendritic cells. Vet Immunol Immunopathol. 2010, 135: 188-198. 10.1016/j.vetimm.2009.11.013.View ArticlePubMedGoogle Scholar
- Auray G, Facci MR, van Kessel J, Buchanan R, Babiuk LA, Gerdts V: Differential activation and maturation of two porcine DC populations following TLR ligand stimulation. Mol Immunol. 2010, 47: 2103-2111. 10.1016/j.molimm.2010.03.016.View ArticlePubMedGoogle Scholar
- Couper KN, Blount DG, Riley EM: IL-10: the master regulator of immunity to infection. J Immunol. 2008, 180: 5771-5777.View ArticlePubMedGoogle Scholar
- Sonck E, Devriendt B, Goddeeris B, Cox E: Varying effects of different β-glucans on the maturation of porcine monocyte-derived dendritic cells. Clin Vaccine Immunol. 2011, 18: 1441-1446. 10.1128/CVI.00080-11.PubMed CentralView ArticlePubMedGoogle Scholar
- Wismar R, Brix S, Laerke HN, Frøkiaer H: Comparative analysis of a large panel of non-starch polysaccharides reveals structures with selective regulatory properties in dendritic cells. Mol Nutr Food Res. 2011, 55: 443-454. 10.1002/mnfr.201000230.View ArticlePubMedGoogle Scholar
- Sheng KC, Pouniotis DS, Wright MD, Tang CK, Lazoura E, Pietersz GA, Apostolopoulos V: Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells. Immunology. 2006, 118: 372-383. 10.1111/j.1365-2567.2006.02384.x.PubMed CentralView ArticlePubMedGoogle Scholar
- Zoumpopoulou G, Tsakalidou E, Dewulf J, Pot B, Grangette C: Differential crosstalk between epithelial cells, dendritic cells and bacteria in a co-culture model. Int J Food Microbiol. 2009, 131: 40-51. 10.1016/j.ijfoodmicro.2008.12.037.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.